ReviewFrontiers in cardiovascular medicine2026
Research progress on the correlation between blood pressure variability and hypertensive microvascular disease.
Review in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The hypertensive microvascular disorder is a significant complication that can lead to substantial target organ damages, including cognitive impairments, visual impairments, and deterioration in renal function. Recent studies have indicated that blood pressure variability (BPV) is an independent risk factor for the progression of this pathology. The present paper aims to systematically elucidate the concept, classification, and clinical significance of BPV, focusing on how it acts as a pathogenic mechanism independent of mean blood pressure to exacerbate endothelial injury and cause target organ damage. This review was conducted to evaluate the influences of multiple factors on BPV, including neurohumoral regulation, the behavioural environment and comorbidities. It also emphasises the intrinsic link between BPV and microvascular complication risk in specific populations, such as those with diabetes and obesity. In summary, it is evident that a comprehensive exploration of the underlying mechanisms of BPV is imperative for the early prevention and treatment of hypertensive microvascular diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.